Found: 5
Select item for more details and to access through your institution.
Development and validation of an analytical method for quantitative determination of three potentially genotoxic impurities in vildagliptin drug material using HPLC‐MS.
- Published in:
- Journal of Separation Science, 2021, v. 44, n. 13, p. 2587, doi. 10.1002/jssc.202100136
- By:
- Publication type:
- Article
HPLC-MS Analysis of Four Potential Genotoxic Impurities in Alogliptin Pharmaceutical Materials.
- Published in:
- Journal of AOAC International, 2022, v. 105, n. 2, p. 362, doi. 10.1093/jaoacint/qsab152
- By:
- Publication type:
- Article
Development and validation of an analytical method for quantification of potential genotoxic impurity 4‐dimethylaminopyridine in linagliptin active pharmaceutical ingredient using Hydrophilic Interaction Liquid Chromatography.
- Published in:
- Separation Science Plus, 2020, v. 3, n. 9, p. 399, doi. 10.1002/sscp.202000056
- By:
- Publication type:
- Article
Trace analysis of potential genotoxic impurity N,N‐dimethylaniline in linagliptin active pharmaceutical ingredient using HPLC.
- Published in:
- Separation Science Plus, 2020, v. 3, n. 7, p. 306, doi. 10.1002/sscp.202000026
- By:
- Publication type:
- Article
Quantitative determination of potential genotoxic impurity 3‐aminopyridine in linagliptin active pharmaceutical ingredient using HILIC–UV.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 11, p. 1, doi. 10.1002/bmc.4930
- By:
- Publication type:
- Article